The WHO classification system for MPNs includes seven subcategories (3), but more commonly this refers to the JAK2 mutation-enriched diseases polycythaemia vera (PV), essential thrombocythaemia (ET) and primary myelofibrosis (PMF). Here, JAK2 is linked to acquired polycythemia vera.